Literature DB >> 8239250

Sudden cardiac death: epidemiology, transient risk, and intervention assessment.

R J Myerburg1, K M Kessler, A Castellanos.   

Abstract

PURPOSE: To integrate information from the various disciplines that contribute to the understanding of the cause and prevention of sudden cardiac death: identification of new approaches from applied clinical epidemiology; identification and control of transient risk factors; and evaluation of the results of interventions. DATA SOURCES: A broad range of research reports and interpretations of data from English-language journal articles and reviews, published primarily between 1970 and 1993. The fields of study included epidemiology, experimental electrophysiology, clinical observations, and interventions. STUDY SELECTION: Continuous literature surveys, done in relation to ongoing clinical and experimental research on sudden cardiac death since 1972. DATA EXTRACTION: Included on the basis of relevance to the topics discussed and with confirmation of data and concepts by more than one investigator when available. DATA SYNTHESIS: Information from several disciplines was integrated by the authors to synthesize new ways to view the problem of sudden cardiac death. Quantitative information was used primarily to derive qualitative statements about new perspectives on sudden cardiac death.
CONCLUSIONS: Progress in the prevention of sudden death will require development of new approaches, including epidemiologic techniques to address risk characteristics specific to the problem; characterization of triggering events and identification of specific persons at risk for responding adversely to these events; and methods of evaluating outcomes appropriate to the nature of sudden cardiac death.

Entities:  

Mesh:

Year:  1993        PMID: 8239250     DOI: 10.7326/0003-4819-119-12-199312150-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  88 in total

Review 1.  The interpretation and clinical application of data from trials on sudden cardiac death.

Authors:  R J Myerburg; R Mitrani; A Interian; J Simmons; M Kloosterman; A Castellanos
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 2.  T-wave alternans and arrhythmia risk stratification.

Authors:  N El-Sherif; G Turitto; R P Pedalino; D Robotis
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

Review 3.  Are drugs and catheter ablation effective for treating ventricular arrhythmias in populations that cannot afford implantable cardioverter defibrillators?

Authors:  K K Talwar; N Naik; R Juneja
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

4.  Hierarchical state space partitioning with a network self-organising map for the recognition of ST-T segment changes.

Authors:  A Bezerianos; L Vladutu; S Papadimitriou
Journal:  Med Biol Eng Comput       Date:  2000-07       Impact factor: 2.602

5.  A common variant in SLC8A1 is associated with the duration of the electrocardiographic QT interval.

Authors:  Jong Wook Kim; Kyung-Won Hong; Min Jin Go; Sung Soo Kim; Yasuharu Tabara; Yoshikuni Kita; Takeshi Tanigawa; Yoon Shin Cho; Bok-Ghee Han; Bermseok Oh
Journal:  Am J Hum Genet       Date:  2012-06-21       Impact factor: 11.025

Review 6.  Drug- and non-drug-associated QT interval prolongation.

Authors:  Charlotte van Noord; Mark Eijgelsheim; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

Review 7.  [Public access defibrillation. Limited use by trained first responders and laymen].

Authors:  S Maisch; P Friederich; A E Goetz
Journal:  Anaesthesist       Date:  2006-12       Impact factor: 1.041

Review 8.  Genetics of sudden cardiac death caused by ventricular arrhythmias.

Authors:  Roos F Marsman; Hanno L Tan; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2013-12-10       Impact factor: 32.419

9.  A common variant at 9p21 is associated with sudden and arrhythmic cardiac death.

Authors:  Christopher Newton-Cheh; Nancy R Cook; Martin VanDenburgh; Eric B Rimm; Paul M Ridker; Christine M Albert
Journal:  Circulation       Date:  2009-11-09       Impact factor: 29.690

10.  Frequency of use of QT-interval prolonging drugs in psychiatry in Belgium.

Authors:  Eline Vandael; Thomas Marynissen; Johan Reyntens; Isabel Spriet; Joris Vandenberghe; Rik Willems; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.